banning semaglutide Ozempic Knock-Offs Contain Unsafe Substance Banned by FDA, Novo Finds Novo Nordisk Urges FDA to

Side-effect monitoring: Watch for injection-site discomfort, headache or nausea

This energy deficit, while promoting weight loss, can result in fatigue, lightheadedness, and generalized weakness, particularly during the initial weeks of treatment or after dose escalation

doi: 10.1016/S2213-8587(14)70174-3 31 WaddenTAHollanderPKleinSNiswenderKWooVHalePMet al

doi: 10.1210/jc.2017-02006 160 JensterleMFerjanSBattelinoTKovaJBattelinoSuputDet al

Some individuals may develop a slight headache, dizziness, or a warm flushing sensation shortly after the injection, though these symptoms usually resolve quickly

Readers should understand that compounded GLP-1 availability may depend on current federal policy, state rules, individual pharmacy requirements, current shortage status, and clinician judgment